purpose. To review outcomes of 106 patients after complete excision of the giant cell tumour of the tendon sheath of the hand, with or without postoperative radiotherapy. Methods. Records of 77 women and 29 men aged 11 to 61 (mean, 31) years who underwent excision of giant cell tumours of the tendon sheath of the hand were reviewed. All patients presented with gradually progressive swelling; only 3 of them also presented with pain. The lesions were located on the dorsal aspect (n=11), the palmar aspect (n=66), both aspects (n=10), or circumferentially (n=14). No patient had multiple lesions. Five patients had bony erosion and 3 had neurovascular bundle involvement. results. The mean follow-up period was 12 (range, 4-22) years. 56 patients with well-encapsulated giant cell tumour in the palmer and/or dorsal aspects were classified as at low risk of recurrence. The remaining 50 patients were classified as at high risk of recurrence and underwent postoperative radiotherapy. None of Giant cell tumour of the tendon sheath of the hand
introduction Giant cell tumour of the tendon sheath (nodular tenosynovitis, localised pigmented villonodular synovitis) is a solitary benign soft-tissue tumour that most commonly occurs in the hand, with recurrence rates of 25 to 45%. [1] [2] [3] [4] Postoperative radiotherapy may reduce the recurrence rate to 4%. 4, 5 We reviewed outcomes of 106 patients after complete excision of the giant cell tumour of the tendon sheath of the hand, with or without postoperative radiotherapy.
Materials and Methods
Records of 77 women and 29 men aged 11 to 61 (mean, 31) years who underwent excision of giant cell tumours of the tendon sheath of the hand between 1986 and 2008 were reviewed. The mean duration of symptoms was 21 (range, 2-96) months. All patients presented with gradually progressive swelling; only 3 of them also presented with pain. The diagnosis was made by preoperative radiography and/or magnetic resonance imaging (n=98) or by histopathological examination (n=8). The lesions were located on the dorsal aspect (n=11), the palmar aspect (n=66), both aspects (n=10), or circumferentially (n=14) [ Table 1 ]. No patient had multiple lesions.
Typical mitosis was noted in 14 lesions. The lesions contained no bone, cartilage, calcification, cartilage debris or necrosis. Five patients had bony erosion. Three patients who had pain preoperatively had neurovascular bundle involvement. Clinical suspicion of neurovascular bundle involvement arises when the patients present with pain. Patients were followed up at week 2, months 3 and 6, year 1, and then yearly thereafter. 
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The mean follow-up period was 12 (range, 4-22) years. 56 patients with well-encapsulated giant cell tumour in the palmer and/or dorsal aspects were classified as at low risk of recurrence. The remaining 50 patients were classified as at high risk of recurrence and underwent postoperative radiotherapy (1.5 Gy daily for 10 days) [ Table 2 and Figs. 1 to 4] . None of the patients at low risk had any recurrence; 4 of those at high risk had recurrence despite radiotherapy. They included one patient with a giant cell tumour in the palmer or dorsal aspect with breach of the capsule, one with a circumferential giant cell tumour, and 2 with a giant cell tumour with bony erosion or incomplete excision. No complication was attributable to the irradiation, except that 3 patients had some dark pigmentation around the wound scar.
discussion
Giant cell tumour of the tendon sheath of the hand has recurrence rates of 25 to 45% after excision. [1] [2] [3] [4] Adjuvant radiotherapy (15-25 Gy, 1.5 Gy daily) is recommended for prevention of recurrence. 6 In our study, postoperative radiotherapy was given to patients at high risk of recurrence. We used to provide radiotherapy to all patients when cells in mitosis were evident on histological examination. Although mitosis indicates activity, but it is just an associated feature and does not predict recurrence (if excision is complete). 7 Radiotherapy may have a role in reducing recurrence of the giant cell tumour of the tendon sheath of the hand. 
